|
|
 |
| |
| Company Name: | Intellipharmaceutics International Inc. |
| Industry: | Pharmaceutical And Medicine Manufacturing |
Symbols/
Instruments: |
| IPCI.H | -Intellipharmaceutics International Inc. |
|
Date of
Listing: | 26 Mar 2024 |
| Fiscal Year-end: | NOV 30 |
| Trading Status: | SUSPENDED |
| Address: | 30 Worcester Rd.
Toronto,
M9W 5X2
Canada
|
| Phone: | 1(416) 798-3001 |
Email
Address: | aodidi@intellipharmaceutics.com |
Senior
Executive: | Amina Odidi, President |
Listed companies wishing to update their information
should click here.
|
|
|
| Info TSX Venture is a comprehensive database of information on NEX listed companies, including: |
|
|
|
|
| |
|
|
| |
© TMX Group Inc. Terms of Use | Privacy Policy
For full optimization and view of this web site, users are recommended to set their screen display at 1024x768 pixels.
TMX Group Inc. and its affiliates do not endorse or recommend any securities issued by any companies identified on, or linked through, this site. Please seek professional advice to evaluate specific securities or other content on this site. Links to third party sites are for informational purposes only and not for trading purposes. TMX Group Inc. and its affiliates have not prepared, reviewed or updated any content on third party sites and assume no responsibility for the information posted on them.
| |
